Hepatic hydrothorax, a rare and debilitating complication of cirrhosis, carries high morbidity and mortality. First-line treatment consists of dietary sodium restriction and diuretic therapy. Some patients, mainly those who are refractory to medical management, will require invasive pleural drainage. The authors report the case of a 76-year-old man in a late cirrhotic stage of alcoholic chronic liver disease, presenting with recurrent right-sided hepatic hydrothorax, portal hypertension, hepatosplenomegaly and thrombocytopaenia. After recurrent admissions and complications, the potential for adjusting diuretic therapy was limited. After unsuccessful talc pleurodesis, an indwelling tunnelled pleural catheter was placed with effective symptom...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax is an uncommon complication in patients with end-stage liver disease. It may res...
Background Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, ...
SummaryWe report a case of successful, long-term pleurovenous shunt (PVS) in treating refractory non...
Background: The outcome of indwelling pleural catheter (IPC) use in hepatic hydrothorax (HH) is uncl...
62-year-old woman admitted to the hospital with dyspnoea, elevated body temperature, cough for two d...
Background: The outcome of indwelling pleural catheter (IPC) use in hepatic hydrothorax (HH) is uncl...
Ascites can occur after hepatic diseases causing dyspnea, coughing and pain. When associated with pl...
Introduction: Liver transplantation is the treatment of choice for decompensated liver disease, and ...
Introduction: Liver transplantation is the treatment of choice for decompensated liver disease, and ...
Pleural effusions develop in 6-10% of patients with endstage liver disease. Although, commonly seen ...
Hepatic hydrothorax (HH) is a transudative pleural effusion that complicates advanced liver cirrhosi...
Hepatic hydrothorax is a pleural effusion occurs in cirrhotic patients without any cardiac and pulmo...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax is an uncommon complication in patients with end-stage liver disease. It may res...
Background Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, ...
SummaryWe report a case of successful, long-term pleurovenous shunt (PVS) in treating refractory non...
Background: The outcome of indwelling pleural catheter (IPC) use in hepatic hydrothorax (HH) is uncl...
62-year-old woman admitted to the hospital with dyspnoea, elevated body temperature, cough for two d...
Background: The outcome of indwelling pleural catheter (IPC) use in hepatic hydrothorax (HH) is uncl...
Ascites can occur after hepatic diseases causing dyspnea, coughing and pain. When associated with pl...
Introduction: Liver transplantation is the treatment of choice for decompensated liver disease, and ...
Introduction: Liver transplantation is the treatment of choice for decompensated liver disease, and ...
Pleural effusions develop in 6-10% of patients with endstage liver disease. Although, commonly seen ...
Hepatic hydrothorax (HH) is a transudative pleural effusion that complicates advanced liver cirrhosi...
Hepatic hydrothorax is a pleural effusion occurs in cirrhotic patients without any cardiac and pulmo...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...
Hepatic hydrothorax can be present in 5-15% of patients with underlying cirrhosis and portal hyperte...